Abstract Enteromorpha prolifera polysaccharide (EP) is a water-soluble sulfated polysaccharide with many types of biological activities. In this study, the crude polysaccharide was extracted from Enteromorpha prolifera and degraded by different physical, chemical, and biological methods. The results showed that the enzymatic degradation products displayed the best tyrosinase inhibitory activity. The optimal enzymatic degradation conditions were as follows: 30 °C, pH 5.5, 750 U/mL enzyme dosage for 2 h. The enzymatic hydrolysates were then divided into six EP fractions (EPFs) by an ultrafiltration membrane. The in vitro tyrosinase inhibitory activity of these fractions showed that the smaller the molecular weight of EPF, the better the inhibitory effect on tyrosinase. The antioxidant and tyrosinase inhibitory effect of the most effective EPF, a molecular weight below 5 kDa, (EPF5), was further confirmed on B16 cells. A kinetic study of tyrosinase inhibitory activity revealed that EPF5 is a competitive-uncompetitive mixed-type inhibitor of tyrosinase. These findings suggested that EPF5 has significant potential as a skin-whitening agent in cosmetics as well as an antibrowning agent in the food and agriculture industries.

ABSTRACT Sugarcane (Saccharum L. spp. hybrids) is a globally important crop. While roots contribute to its net primary production, knowledge of sugarcane root growth is incomplete and limited in scope. The objective of this study was to determine cumulative root density (LA), root distribution, effective rooting depth (ERD), and root growth rate for four sugarcane genotypes across three crop cycles (plant cane [PC], first ratoon [FR], and second ratoon [SR]). The experiment was conducted in a rain shelter on four sugarcane genotypes (ROC22, YZ04-241, YZ05-194, and YZ05-51) using minirhizotron tubes to a soil profile depth of 1.08 m. Most roots in were found at 0–0.36 m-depth, and about 85.0% were within a 0–0.72 m depth in PC. In FR and SR, however, > 81.8% of roots were found at 0–0.54 m-depth regardless of genotype. The LA of ROC22 was often significantly higher than that of the other genotypes at depths < 0.54 m regardless of crop cycle. The genotype ROC22 had greater root length and faster root growth rate than YZ05-194 at 0.18–0.36 m in PC and FR, while SR YZ05-194 had slower root growth than the other genotypes at 0–0.18m. Ratooning ability of sugarcane genotypes may be related to these root growth attributes.

Abstract Background: Prunella vulgaris L. has been an important medicinal plant for the treatment of thyroid gland malfunction and mastitis in China for over 2000 years. There is an urgent need to select effective wavelengths for greenhouse cultivation of P. vulgaris as light is a very important factor in P. vulgaris growth. Here, we described the effects of natural light (control) and UV solar exclusion on the morphological and physiological traits, secondary metabolites contents and antioxidant activities of P. vulgaris. Results: The results showed that UV solar exclusion resulted in remarkable alterations to morphological and biomass traits; significantly reduced the chlorophyll a, chlorophyll b and total chlorophyll contents; significantly enhanced the ratio of chlorophyll a to b; and significantly increased the carotenoid and anthocyanin contents in P. vulgaris. UV solar exclusion significantly increased the catalase (CAT) and peroxidase (POD) activities, increased superoxide dismutase (SOD) and ascorbate peroxidase (APX) activities and slightly decreased the glutathione (GSH) content. UV solar exclusion significantly increased the soluble sugar and H2O2 contents and increased the soluble protein content but significantly decreased the proline content and slightly decreased the MDA content. The secondary metabolite contents (total phenolics, rosmarinic acid, caffeic acid, hyperoside, ursolic acid and oleanolic acid) and in vitro antioxidative properties (DPPH· and ABTS·+scavenging activities) were significantly increased in P. vulgaris spicas under UV solar exclusion. Additionally, the total polysaccharide and total flavonoids contents were slightly increased by UV solar exclusion. The salviaflaside content was significantly reduced by UV solar exclusion. Conclusion: Our study demonstrated that P. vulgaris activates several antioxidant defence systems against oxidative damage caused by UV solar exclusion.

Abstract Purpose: To investigate the effect of alprostadil on myocardial ischemia/reperfusion (I/R) in rats. Methods: Rats were subjected to myocardial ischemia for 30 min followed by 24h reperfusion. Alprostadil (4 or 8 μg/kg) was intravenously administered at the time of reperfusion and myocardial infarct size, levels of troponin T, and the activity of creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) in the serum were measured. Antioxidative parameters, nitric oxide (NO) content and phosphorylated endothelial nitric oxide synthase 3 (p-eNOS) expression in the left ventricles were also measured. Histopathological examinations of the left ventricles were also performed. Results: Alprostadil treatment significantly reduced myocardial infarct size, serum troponin T levels, and CK-MB and LDH activity (P<0.05). Furthermore, treatment with alprostadil significantly decreased malondialdehyde (MDA) content (P<0.05) and markedly reduced myonecrosis, edema and infiltration of inflammatory cells. Superoxide dismutase and catalase activities (P<0.05), NO level (P<0.01) and p-eNOS (P<0.05) were significantly increased in rats treated with alprostadil compared with control rats. Conclusion: These results indicate that alprostadil protects against myocardial I/R injury and that these protective effects are achieved, at least in part, via the promotion of antioxidant activity and activation of eNOS.

摘要 目的 旨在确定上海地区肺结核病患者的超额死亡率。 方法 参与者是曾于2004 年 1 月 1 日至 2008 年 12 月 31 日在四家肺结核病诊所其中一家登记过的、上海市 4 个区（共 19 个区）的当地居民。我们收集了最近的肺结核病诊断的基线数据，并对 2014 年 3 月至 5 月的死亡率进行了评估。我们计算出所有参与者和子组的标准化死亡率和病死率，并采用单变量和多变量 Cox 回归模型量化各种原因与肺结核导致的共病症与死亡率之间的关联。 结果 我们登记了病患中 4569 名受试者。总体而言，各种原因导致的死亡患者的标准化死亡率为 5.2 （95% 置信区间：4.8-5.6）。男性的标准化死亡率高于女性 (6.1 比 3.0)。调整年龄和性别后，以前接受过治疗的患者（风险比：1.26，95% 置信区间：1.08-1.49）和痰涂片试验呈阳性的患者（风险比：1.55，95% 置信区间：1.35-1.78）中各种原因导致的死亡风险比明显更高。以前接受过治疗的患者（风险比率：1.88，95% 置信区间：1.24-2.86）和痰涂片试验呈阳性的患者（风险比率：3.16，95% 置信区间：2.06-4.87）中肺结核导致的死亡风险也明显更高。 结论 上海地区肺结核病患者的死亡率风险增加。及早的诊断和更加警觉的随访诊查可能有助于降低肺结核患者的死亡率。

Résumé Objectif Déterminer la surmortalité dans une cohorte de personnes atteintes de tuberculose à Shanghai. Méthodes Les participants étaient des habitants de 4 districts (sur 19) de Shanghai, enregistrés dans une des quatre cliniques de la tuberculose entre le 1er janvier 2004 et le 31 décembre 2008. Des données de référence ont été recueillies lors du diagnostic le plus récent de tuberculose et la mortalité a été évaluée entre mars et mai 2014. Nous avons calculé les rapports standardisés de mortalité (RSM) et les taux de létalité pour tous les participants ainsi que pour des sous-groupes. Des modèles de régression univariée et multivariée de Cox ont été utilisés pour quantifier les associations entre les comorbidités et la mortalité, toutes causes confondues et due à la tuberculose. Résultats Nous avons enregistré 4569 sujets dans la cohorte. Globalement, la cohorte avait un RSM pour les décès toutes causes confondues de 5,2 (intervalle de confiance (IC) de 95%: 4,8-5,6). Les hommes affichaient un RSM plus élevé que les femmes (6,1 contre 3,0). Après ajustement en fonction de l'âge et du sexe, les ratios de risque (RR) de décès toutes causes confondues étaient nettement plus élevés chez les personnes ayant précédemment reçu un traitement (RR: 1,26; IC 95%: 1,08-1,49) et les personnes à frottis d'expectoration positif (RR: 1,55; IC 95%: 1,35-1,78). Le risque de décès dû à la tuberculose était également beaucoup plus important pour les personnes ayant précédemment reçu un traitement (RR: 1,88; IC 95%: 1,24-2,86) et les personnes à frottis positif (RR: 3,16; IC 95%: 2,06-4,87). Conclusion Les personnes atteintes de tuberculose à Shanghai présentent un risque accru de mortalité. Un diagnostic plus précoce et un suivi plus attentif pourraient permettre de réduire la mortalité dans ce groupe.

абстрактный доступен в Полный текст

Abstract Objective To determine excess mortality in a cohort of people with tuberculosis in Shanghai. Methods Participants were local residents in 4 (of 19) districts in Shanghai, registered in one of four tuberculosis clinics between January 1, 2004 and December 31, 2008. Baseline data were collected at the most recent diagnosis of tuberculosis and mortality was assessed between March and May of 2014. We calculated standardized mortality ratios (SMR) and case-fatality rates for all participants and for subgroups. Univariate and multivariate Cox regression models were used to quantify associations between co-morbidities and mortality from all causes and from tuberculosis. Findings We registered 4569 subjects in the cohort. Overall, the cohort had an SMR for deaths from all causes of 5.2 (95% confidence interval, CI: 4.8-5.6). Males had a higher SMR than females (6.1 versus 3.0). After adjustment for age and sex, hazard ratios (HR) for deaths from all causes were significantly greater in previously treated people (HR: 1.26; 95% CI: 1.08-1.49) and sputum smear-test positive people (HR: 1.55; 95% CI: 1.35-1.78). The risk of death from tuberculosis was also significantly greater for previously treated people (HR: 1.88; 95% CI: 1.24-2.86) and smear positive people (HR: 3.16; 95% CI: 2.06-4.87). Conclusion People with tuberculosis in Shanghai have an increased risk of mortality. Earlier diagnosis and more vigilant follow-up may help to reduce mortality in this group.

ملخص الغرض تحديد الزيادة في حالات الوفاة في مجموعة من المصابين بالسل في شانغهاي. الطريقة كان المشاركون من السكان المحليين في 4 أحياء (من بين 19 حيًا) في شنغهاي، وقد تم تسجيلهم في واحدة من أربع عيادات لعلاج السل في الفترة بين 1 يناير/كانون الثاني 2004 و31 ديسمبر/كانون الأول 2008. وقد تم جمع البيانات الأساسية على مستوى أحدث الحالات التي تم تشخيصها كحالات الإصابة بالسل، كما تم تقدير الوفيات في الفترة بين شهري مارس/آذار ومايو/أيار 2014. وحسبنا نسب الوفيات القياسية (SMR) ومعدلات الوفيات بين الحالات المصابة بالنظر إلى جميع المشاركين والمجموعات الفرعية.وتم استخدام نماذج انحدار كوكس ذات المتغير الأحادي والمتعددة المتغيرات لقياس مدى الارتباط بين الإصابة بأكثر من مرض في نفس الوقت وحالات الوفاة الناتجة عن جميع الأسباب والناتجة عن مرض السل. النتائج سجلنا 4569 من الحالات محل الدراسة في المجموعة المشار إليها.وبوجه عام، بلغت نسبة الوفيات القياسية الناتجة عن جميع الأسباب في هذه المجموعة 5.2 (بنسبة أرجحية مقدارها 95%: 4.8-5.6). وارتفعت نسبة الوفيات القياسية بين الرجال مقارنةً بالنساء (6.1 مقابل 3.0).وبعد تعديل عامل العمر والجنس، كانت نسب خطورة (HR) التعرض للوفاة الناتجة عن جميع الأسباب أكثر ارتفاعًا بشكل ملحوظ لدى الأشخاص الذين سبقت معالجتهم (نسبة خطورة: 1.26؛ بنسبة أرجحية مقدارها 95%: 1.08- 1.49) ولدى الأشخاص الذين كانت نتائج اختبار مسحة البلغم الخاصة بهم إيجابية (HR: 1.55؛ بنسبة أرجحية مقدارها 95%: 1.35-1.78). وكان خطر الوفاة الناتجة عن السل أكثر ارتفاعًا أيضًا بشكل ملحوظ لدى الأشخاص الذين سبقت معالجتهم (نسبة خطورة: 1.88؛ بنسبة أرجحية مقدارها 95%: 1.24- 2.86) ولدى الأشخاص الذين كانت نتائج المسحة الخاصة بهم إيجابية (نسبة خطورة: 3.16؛ بنسبة أرجحية مقدارها 95%: 2.06-4.87). الاستنتاج يعاني المصابون بالسل في شانغهاي من زيادة خطر التعرض للوفاة. وقد يساعد التشخيص المبكر للمرض والمزيد من المتابعة الطبية الدقيقة في تقليل معدل الوفيات في هذه المجموعة.

Resumen Objetivo Determinar el exceso de mortalidad en una cohorte de personas con tuberculosis en Shanghái. Métodos Los participantes eran residentes locales de 4 (de 19) distritos de Shanghái, registrados en uno de los cuatro consultorios antituberculosos entre el 1 de enero de 2004 y el 31 de diciembre de 2008. Se recogieron datos de referencia de los diagnósticos de tuberculosis más recientes y se evaluó la mortalidad entre marzo y mayo de 2014. Se calcularon las tasas de mortalidad estandarizadas (SMR) y la tasa de letalidad de todos los participantes y por subgrupos. Se utilizaron modelos de regresión de Cox univariables y multivariables para cuantificar las asociaciones entre la comorbilidad y la mortalidad de todas las causas de tuberculosis. Resultados Se registraron 4.569 sujetos en la cohorte. En general, la cohorte tenía una SMR para muertes de todas las causas de 5,2 (intervalo de confianza del 95%, IC: 4,8-5,6). Los hombres tenían una SMR mayor que las mujeres (6,1 frente a 3,0). Tras ajustarlos de acuerdo a edad y sexo, los cocientes de riesgo (HR) para las muertes de todas las causas eran significantemente mayores en personas tratadas con anterioridad (HR: 1,26 (IC del 95%: 1,08-1,49) y personas con pruebas de esputo positivas (HR: 1,55 (IC del 95%: 1,35-1,78). El riesgo de muerte por tuberculosis también era significativamente mayor en personas tratadas con anterioridad (HR: 1,88 (IC del 95%: 1,24-2,86) y personas con pruebas de esputo positivas (HR: 3,16 (IC del 95%: 2,06-4,87). Conclusión Las personas con tuberculosis en Shanghái tienen un mayor riesgo de mortalidad. Unos diagnósticos más tempranos y un seguimiento más atento podrían ayudar a reducir la mortalidad de este grupo.

The current study was designed to evaluate the aqueous extract of Terminalia chebula activity, and the main pathway was detected on lung cancer by extracts of T. chebula. Aqueous extract of T. chebula was separated using a zeolite, and five fractions of T. chebula extract were obtained and analyzed by ultraviolet (UV) and infrared (IR) spectroscopy. Antiproliferative activity was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) methods against human lung cancer (A549) and mouse lung cancer cell line LLC. T. chebula acts by regulating the Bcl-2 family protein-mediated mitochondrial pathway detected by western blot. Fraction 4 of the T. chebula extract showed much function and was thus studied further. Fraction 4 increased the activation of caspase-3, induced PARP cleavage, and promoted cytochrome c release into the cytoplasm. These data suggest that T. chebula acts by regulating the Bcl-2 family protein-mediated mitochondrial pathway and provide evidence that T. chebula deserves further investigation as a natural agent for treating and preventing cancer.

Fundamento:Os resultados a longo prazo dos stents farmacológicos (SF) contra stents convencionais (SC) em pacientes com infarto do miocárdio com elevação do segmento ST (IMEST) permanecem incertos.Objetivo:Investigar os resultados a longo prazo dos stents farmacológicos (SF) contra stents convencionais (SC) em pacientes com infarto do miocárdio com elevação do segmento ST (IMEST) .Métodos:Foi realizada pesquisa de dados nas bases de dados MEDLINE, EMBASE, na Cochrane Library, e na ISI Web of Science (até fevereiro de 2013) para estudos clínicos aleatórios que comparam a eficácia durante mais de 12 meses ou a segurança do SF com SC em pacientes com IMEST. Foi apresentada uma estimativa agrupada com risco relativo (RR) e seu intervalo de confiança de 95 % (IC), utilizando modelo de efeitos aleatórios.Resultados:Dez estudos com 7.592 participantes com IMEST foram incluídos. Os resultados gerais mostraram que não houve diferença significativa na incidência de morte por todas as causas e trombose de stent definida/provável entre SF e SC em seguimento de longo prazo. Os pacientes que receberam implante de SF pareciam ter uma incidência de infarto do miocárdio recorrente inferior a1 ano que aqueles que receberam SC (RR = 0,75, 95% CI 0,56-1,00, p = 0,05). Além disso, o risco de revascularização do vaso alvo (RVA) depois de receber o SF diminui consistentemente durante a observação a longo prazo (todos p <0,01). Na análise de subgrupo, o uso de stents com eluição de everolimus (EEE) foi associado a um risco reduzido de trombose de stent em pacientes IMEST (RR = 0,37, p = 0,02).Conclusões:SF não aumentou o risco de trombose de stent em pacientes com IMEST em comparação com SC. Além disso, o uso de SF fez baixar o risco de longo prazo de repetição da revascularização e pôde diminuir a ocorrência de reinfarto.

Background:Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) remain uncertain.Objective:To investigate long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI).Methods:We performed search of MEDLINE, EMBASE, the Cochrane library, and ISI Web of Science (until February 2013) for randomized trials comparing more than 12-month efficacy or safety of DES with BMS in patients with STEMI. Pooled estimate was presented with risk ratio (RR) and its 95% confidence interval (CI) using random-effects model.Results:Ten trials with 7,592 participants with STEMI were included. The overall results showed that there was no significant difference in the incidence of all-cause death and definite/probable stent thrombosis between DES and BMS at long-term follow-up. Patients receiving DES implantation appeared to have a lower 1-year incidence of recurrent myocardial infarction than those receiving BMS (RR = 0.75, 95% CI 0.56 to 1.00, p= 0.05). Moreover, the risk of target vessel revascularization (TVR) after receiving DES was consistently lowered during long-term observation (all p< 0.01). In subgroup analysis, the use of everolimus-eluting stents (EES) was associated with reduced risk of stent thrombosis in STEMI patients (RR = 0.37, p=0.02).Conclusions:DES did not increase the risk of stent thrombosis in patients with STEMI compared with BMS. Moreover, the use of DES did lower long-term risk of repeat revascularization and might decrease the occurrence of reinfarction.

The mechanisms of exercise-induced fatigue have not been investigated using proteomic techniques, an approach that could improve our understanding and generate novel information regarding the effects of exercise. In this study, the proteom alterations of rat skeletal muscle were investigated during exercise-induced fatigue. The proteins were extracted from the skeletal muscle of SD rat thigh, and then analyzed by two-dimensional electrophoresis and PDQuest software. Compared to control samples, 10 significantly altered proteins were found in exercise samples, two of them were upregulated and eight of them were downregulated. These proteins were identified by MALDI TOF-MS. The two upregulated proteins were identified as MLC1 and myosin L2 (DTNB) regulatory light-chain precursors. The eight decreased proteins are Glyceraldehyde-3-phosphate Dehydrogenas (GAPDH); Beta enolase; Creatine kinase M chain (M-CK); ATP-AMP Transphosphorylase (AK1); myosin heavy chain (MHC); actin; Troponin I, fast-skeletal muscle (Troponin I fast-twitch isoform), fsTnI; Troponin T, fast-skeletal muscle isoforms (TnTF). In these proteins, four of the eight decreased proteins are related directly or indirectly to exercise induced fatigue. The other proteins represent diverse sets of proteins including enzymyes related to energy metabolism, skeletal muscle fabric protein and protein with unknown functions. They did not exhibit evident relationship with exercise-induced fatigue. Whereas the two identified increased proteins exhibit evident relationship with fatigue. These findings will help in understanding the mechanisms involved in exercise-induced fatigue.

CXCL-12 and its receptor CXCR4 participate in breast cancer and melanoma cell metastasis to bone and lymphoid nodes. CD44, as a receptor for hyaluronic acid, is involved in lymphocyte recirculation, homing, adhesion and migration. But the role of CD44 in CXCL-12 induced leukemia cell migration still remains unclear. The present study showed that CXCL-12 stimulation induced the rapid internalization of CXCR4 and facilitated the formation of lamellipodia and uropod in acute leukemia cell line HL-60. CXCL-12 also induced CD44 translocation into the uropod, while CD44 remained evenly distributed on the untreated cell membranes. Results suggest that CD44 participates in CXCL-12 induced cell polarization and subsequent cell migration.